QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization
NCT ID: NCT00918294
Last Updated: 2019-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2007-09-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
QuickOpt Chronic Study
NCT01172067
Acute and Cronic Evaluation of AV/PV and VV Delay IEGM Based Optimisation Algorithm-QuickSept Study
NCT02571868
Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy.
NCT00489177
BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement
NCT00929474
Quadripolar Pacing Post Approval Study
NCT01555619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
QuickOpt
QuickOpt is an optimization algorithm to program the AV, PV and VV delays
QuickOpt
The QuickOpt algorithm will suggest values for programming AV, PV and VV delay.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QuickOpt
The QuickOpt algorithm will suggest values for programming AV, PV and VV delay.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is able to provide written informed consent for study participation
Exclusion Criteria
* Patient has persistent or permanent AF
* Patient has a 2o or 3o heart block
* Patient is unable to provide analyzable echocardiogram images
* Patient's life expectancy is \<12 months
* Patient is \<18 years old
* Patient is pregnant
* Patient is on IV inotropic agents
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fu Wai Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hua W, Wang DM, Cai L, Sun CF, Fu GS, Wang YT, Yan J, Luo ZL, Xu J, Wang ZY, Xu G, Shen FR, Xu W, Wang JF, Ren XJ, Jin W, Zhang N, Lau EO, Zhang S. A prospective study to evaluate the efficacy of an intracardiac electrogram-based atrioventricular and interventricular intervals optimization method in cardiac resynchronization therapy. Chin Med J (Engl). 2012 Feb;125(3):428-33.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QuickOpt Study Asia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.